192 related articles for article (PubMed ID: 37369086)
1. The risk of secondary progressive multiple sclerosis is geographically determined but modifiable.
Sharmin S; Roos I; Simpson-Yap S; Malpas C; Sánchez MM; Ozakbas S; Horakova D; Havrdova EK; Patti F; Alroughani R; Izquierdo G; Eichau S; Boz C; Zakaria M; Onofrj M; Lugaresi A; Weinstock-Guttman B; Prat A; Girard M; Duquette P; Terzi M; Amato MP; Karabudak R; Grand'Maison F; Khoury SJ; Grammond P; Lechner-Scott J; Buzzard K; Skibina O; van der Walt A; Butzkueven H; Turkoglu R; Altintas A; Maimone D; Kermode A; Shalaby N; Pesch VV; Butler E; Sidhom Y; Gouider R; Mrabet S; Gerlach O; Soysal A; Barnett M; Kuhle J; Hughes S; Sa MJ; Hodgkinson S; Oreja-Guevara C; Ampapa R; Petersen T; Ramo-Tello C; Spitaleri D; McCombe P; Taylor B; Prevost J; Foschi M; Slee M; McGuigan C; Laureys G; Hijfte LV; de Gans K; Solaro C; Oh J; Macdonell R; Aguera-Morales E; Singhal B; Gray O; Garber J; Wijmeersch BV; Simu M; Castillo-Triviño T; Sanchez-Menoyo JL; Khurana D; Al-Asmi A; Al-Harbi T; Deri N; Fragoso Y; Lalive PH; Sinnige LGF; Shaw C; Shuey N; Csepany T; Sempere AP; Moore F; Decoo D; Willekens B; Gobbi C; Massey J; Hardy T; Parratt J; Kalincik T
Brain; 2023 Nov; 146(11):4633-4644. PubMed ID: 37369086
[TBL] [Abstract][Full Text] [Related]
2. The natural history of multiple sclerosis: a geographically based study 10: relapses and long-term disability.
Scalfari A; Neuhaus A; Degenhardt A; Rice GP; Muraro PA; Daumer M; Ebers GC
Brain; 2010 Jul; 133(Pt 7):1914-29. PubMed ID: 20534650
[TBL] [Abstract][Full Text] [Related]
3. Disease-modifying therapies in managing disability worsening in paediatric-onset multiple sclerosis: a longitudinal analysis of global and national registries.
Sharmin S; Roos I; Malpas CB; Iaffaldano P; Simone M; Filippi M; Kubala Havrdova E; Ozakbas S; Brescia Morra V; Alroughani R; Zaffaroni M; Patti F; Eichau S; Salemi G; Di Sapio A; Inglese M; Portaccio E; Trojano M; Amato MP; Kalincik T; ;
Lancet Child Adolesc Health; 2024 May; 8(5):348-357. PubMed ID: 38547883
[TBL] [Abstract][Full Text] [Related]
4. Risk of secondary progressive multiple sclerosis: A longitudinal study.
Fambiatos A; Jokubaitis V; Horakova D; Kubala Havrdova E; Trojano M; Prat A; Girard M; Duquette P; Lugaresi A; Izquierdo G; Grand'Maison F; Grammond P; Sola P; Ferraro D; Alroughani R; Terzi M; Hupperts R; Boz C; Lechner-Scott J; Pucci E; Bergamaschi R; Van Pesch V; Ozakbas S; Granella F; Turkoglu R; Iuliano G; Spitaleri D; McCombe P; Solaro C; Slee M; Ampapa R; Soysal A; Petersen T; Sanchez-Menoyo JL; Verheul F; Prevost J; Sidhom Y; Van Wijmeersch B; Vucic S; Cristiano E; Saladino ML; Deri N; Barnett M; Olascoaga J; Moore F; Skibina O; Gray O; Fragoso Y; Yamout B; Shaw C; Singhal B; Shuey N; Hodgkinson S; Altintas A; Al-Harbi T; Csepany T; Taylor B; Hughes J; Jun JK; van der Walt A; Spelman T; Butzkueven H; Kalincik T
Mult Scler; 2020 Jan; 26(1):79-90. PubMed ID: 31397221
[TBL] [Abstract][Full Text] [Related]
5. Natural history of multiple sclerosis: a unifying concept.
Confavreux C; Vukusic S
Brain; 2006 Mar; 129(Pt 3):606-16. PubMed ID: 16415308
[TBL] [Abstract][Full Text] [Related]
6. Risk of secondary progressive multiple sclerosis after early worsening of disability.
Dzau W; Sharmin S; Patti F; Izquierdo G; Eichau S; Prat A; Girard M; Duquette P; Onofrj M; Lugaresi A; Ozakbas S; Gerlach O; Boz C; Grammond P; Terzi M; Amato MP; La Spitaleri D; Ramo-Tello C; Maimone D; Cartechini E; Buzzard K; Skibina O; van der Walt A; Butzkueven H; Iuliano G; Soysal A; Kalincik T
J Neurol Neurosurg Psychiatry; 2023 Dec; 94(12):984-991. PubMed ID: 37414538
[TBL] [Abstract][Full Text] [Related]
7. Association of Sustained Immunotherapy With Disability Outcomes in Patients With Active Secondary Progressive Multiple Sclerosis.
Lizak N; Malpas CB; Sharmin S; Havrdova EK; Horakova D; Izquierdo G; Eichau S; Lugaresi A; Duquette P; Girard M; Prat A; Larochelle C; Trojano M; Grand'Maison F; Grammond P; Sola P; Ferraro D; Hupperts R; Bergamaschi R; Boz C; Van Pesch V; Spitaleri D; Terzi M; Kalincik T;
JAMA Neurol; 2020 Nov; 77(11):1398-1407. PubMed ID: 32716480
[TBL] [Abstract][Full Text] [Related]
8. A national registry-based study of ethnic differences in people with multiple sclerosis in Iran.
Ashtari F; Kavosh A; Baghbanian SM; Hosseini Nejad Mir N; Hosseini S; Razazian N; Majdinasab N; Farajzadegan Z; Shaygannejad V; Adibi I; Eskandarieh S; Sahraian MA
Clin Neurol Neurosurg; 2024 Apr; 239():108216. PubMed ID: 38490075
[TBL] [Abstract][Full Text] [Related]
9. Do disease-modifying drugs (DMD) have a positive impact on the occurrence of secondary progressive multiple sclerosis? Comment.
Ouallet JC
Rev Neurol (Paris); 2020 Jun; 176(6):500-504. PubMed ID: 32278541
[TBL] [Abstract][Full Text] [Related]
10. Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort study.
Kalincik T; Brown JWL; Robertson N; Willis M; Scolding N; Rice CM; Wilkins A; Pearson O; Ziemssen T; Hutchinson M; McGuigan C; Jokubaitis V; Spelman T; Horakova D; Havrdova E; Trojano M; Izquierdo G; Lugaresi A; Prat A; Girard M; Duquette P; Grammond P; Alroughani R; Pucci E; Sola P; Hupperts R; Lechner-Scott J; Terzi M; Van Pesch V; Rozsa C; Grand'Maison F; Boz C; Granella F; Slee M; Spitaleri D; Olascoaga J; Bergamaschi R; Verheul F; Vucic S; McCombe P; Hodgkinson S; Sanchez-Menoyo JL; Ampapa R; Simo M; Csepany T; Ramo C; Cristiano E; Barnett M; Butzkueven H; Coles A;
Lancet Neurol; 2017 Apr; 16(4):271-281. PubMed ID: 28209331
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of first generation disease-modifying therapy to prevent conversion to secondary progressive multiple sclerosis.
Tedeholm H; Piehl F; Lycke J; Link J; Stawiarz L; Burman J; de Flon P; Fink K; Gunnarsson M; Mellergård J; Nilsson P; Sundström P; Svenningsson A; Johansson H; Andersen O
Mult Scler Relat Disord; 2022 Dec; 68():104220. PubMed ID: 36242804
[TBL] [Abstract][Full Text] [Related]
12. Relapses and progression of disability in multiple sclerosis.
Confavreux C; Vukusic S; Moreau T; Adeleine P
N Engl J Med; 2000 Nov; 343(20):1430-8. PubMed ID: 11078767
[TBL] [Abstract][Full Text] [Related]
13. Transition to secondary progression in relapsing-onset multiple sclerosis: Definitions and risk factors.
Iaffaldano P; Lucisano G; Patti F; Brescia Morra V; De Luca G; Lugaresi A; Zaffaroni M; Inglese M; Salemi G; Cocco E; Conte A; Ferraro D; Galgani S; Bergamaschi R; Pozzilli C; Salvetti M; Lus G; Rovaris M; Maniscalco GT; Logullo FO; Paolicelli D; Achille M; Marrazzo G; Lovato V; Comi G; Filippi M; Amato MP; Trojano M;
Mult Scler; 2021 Mar; 27(3):430-438. PubMed ID: 33210986
[TBL] [Abstract][Full Text] [Related]
14. Mitoxantrone in relapsing-remitting and rapidly progressive multiple sclerosis: Ten-year clinical outcomes post-treatment with mitoxantrone.
Foo EC; Russell M; Lily O; Ford HL
Mult Scler Relat Disord; 2020 Sep; 44():102330. PubMed ID: 32599468
[TBL] [Abstract][Full Text] [Related]
15. Association of Inflammation and Disability Accrual in Patients With Progressive-Onset Multiple Sclerosis.
Hughes J; Jokubaitis V; Lugaresi A; Hupperts R; Izquierdo G; Prat A; Girard M; Duquette P; Grand'Maison F; Grammond P; Sola P; Ferraro D; Ramo-Tello C; Trojano M; Slee M; Shaygannejad V; Boz C; Lechner-Scott J; Van Pesch V; Pucci E; Solaro C; Verheul F; Terzi M; Granella F; Spitaleri D; Alroughani R; Jun JK; Fambiatos A; Van der Walt A; Butzkueven H; Kalincik T;
JAMA Neurol; 2018 Nov; 75(11):1407-1415. PubMed ID: 30083762
[TBL] [Abstract][Full Text] [Related]
16. The natural history of multiple sclerosis: a geographically based study. 7. Progressive-relapsing and relapsing-progressive multiple sclerosis: a re-evaluation.
Kremenchutzky M; Cottrell D; Rice G; Hader W; Baskerville J; Koopman W; Ebers GC
Brain; 1999 Oct; 122 ( Pt 10)():1941-50. PubMed ID: 10506095
[TBL] [Abstract][Full Text] [Related]
17. Variability of the response to immunotherapy among subgroups of patients with multiple sclerosis.
Diouf I; Malpas CB; Sharmin S; Roos I; Horakova D; Havrdova EK; Patti F; Shaygannejad V; Ozakbas S; Izquierdo G; Eichau S; Onofrj M; Lugaresi A; Alroughani R; Prat A; Girard M; Duquette P; Terzi M; Boz C; Grand'Maison F; Hamdy S; Sola P; Ferraro D; Grammond P; Turkoglu R; Buzzard K; Skibina O; Yamout B; Altintas A; Gerlach O; van Pesch V; Blanco Y; Maimone D; Lechner-Scott J; Bergamaschi R; Karabudak R; Iuliano G; McGuigan C; Cartechini E; Barnett M; Hughes S; Sa MJ; Solaro C; Kappos L; Ramo-Tello C; Cristiano E; Hodgkinson S; Spitaleri D; Soysal A; Petersen T; Slee M; Butler E; Granella F; de Gans K; McCombe P; Ampapa R; Van Wijmeersch B; van der Walt A; Butzkueven H; Prevost J; Sinnige LGF; Sanchez-Menoyo JL; Vucic S; Laureys G; Van Hijfte L; Khurana D; Macdonell R; Gouider R; Castillo-Triviño T; Gray O; Aguera-Morales E; Al-Asmi A; Shaw C; Deri N; Al-Harbi T; Fragoso Y; Csepany T; Perez Sempere A; Trevino-Frenk I; Schepel J; Moore F; Kalincik T
Eur J Neurol; 2023 Apr; 30(4):1014-1024. PubMed ID: 36692895
[TBL] [Abstract][Full Text] [Related]
18. A representative cohort of patients with non-progressive multiple sclerosis at the age of normal life expectancy.
Skoog B; Runmarker B; Winblad S; Ekholm S; Andersen O
Brain; 2012 Mar; 135(Pt 3):900-11. PubMed ID: 22366800
[TBL] [Abstract][Full Text] [Related]
19. Geographical variations in sex ratio trends over time in multiple sclerosis.
Trojano M; Lucchese G; Graziano G; Taylor BV; Simpson S; Lepore V; Grand'maison F; Duquette P; Izquierdo G; Grammond P; Amato MP; Bergamaschi R; Giuliani G; Boz C; Hupperts R; Van Pesch V; Lechner-Scott J; Cristiano E; Fiol M; Oreja-Guevara C; Saladino ML; Verheul F; Slee M; Paolicelli D; Tortorella C; D'Onghia M; Iaffaldano P; Direnzo V; Butzkueven H;
PLoS One; 2012; 7(10):e48078. PubMed ID: 23133550
[TBL] [Abstract][Full Text] [Related]
20. Does initial high efficacy therapy in multiple sclerosis surpass escalation treatment strategy? A comparison of patients with relapsing-remitting multiple sclerosis in the Czech and Swedish national multiple sclerosis registries.
Hrnciarova T; Drahota J; Spelman T; Hillert J; Lycke J; Kubala Havrdova E; Recmanova E; Adamkova J; Mares J; Libertinova J; Pavelek Z; Hradilek P; Ampapa R; Stetkarova I; Peterka M; Martinkova A; Stourac P; Grunermelova M; Vachova M; Dufek M; Horakova D
Mult Scler Relat Disord; 2023 Aug; 76():104803. PubMed ID: 37329786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
